Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the self-administered parenteral market grown over the years?
The self-administered parenteral market has seen strong growth, forecasted to increase from $24.57 billion in 2024 to $26.04 billion in 2025 at a CAGR of 6.0%. Factors behind this growth include a rise in chronic diseases, an aging population, government healthcare initiatives, patient education programs, and the increasing prevalence of bone disorders.
What Is the forecasted market size and growth rate for the self-administered parenteral market?
The self-administered parenteral market is projected to grow steadily, reaching $31.18 billion in 2029, with a 4.6% CAGR. Growth is attributed to rising home healthcare adoption, telemedicine expansion, patient education initiatives, and personalized medicine advancements. Key trends include digital health integration, customized drug delivery systems, targeted therapies, and biologics innovation.
Get your self-administered parenteral market report here!
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report
What are the major factors driving growth in the self-administered parenteral market?
The escalation in chronic disease cases is anticipated to fuel the expansion of the self-administered parenteral market. Chronic diseases are enduring health problems that typically advance sluggishly over time, often necessitating continuous management and therapy. Self-administered parenteral products play a crucial role in managing chronic diseases, facilitating treatment management independently and potentially enhancing adherence compared to oral medication. For example, in January 2023, the National Institutes of Health, a U.S. government agency, projected that the number of individuals aged 50 and above with at least one chronic disease would surge by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Hence, the increasing prevalence of chronic diseases is propelling the expansion of the self-administered parenteral market.
What key areas define the segmentation of the global self-administered parenteral Market?
The self-administered parenteral market covered in this report is segmented –
1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications
Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp
What are the top market players propelling the growth of the self-administered parenteral industry?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG
What are the key trends shaping the future of the self-administered parenteral market?
Leading businesses in the self-administered parenteral market, such as Coherus BioSciences Inc., are seeking to evolve with innovative product developments like the UDENYCA autoinjector, aiming to give more options and power to the patients, thereby enhancing the accessibility of the treatments. An autoinjector, by design, is a medical instrument developed to deliver a specific one-time drug dose, and the administration of the same is instantly and reliably initiated when pushed against the skin. To put it in context, in May 2023, Coherus BioSciences Inc, a biotech firm based in the US, premiered the UDENYCA autoinjector, a type of self-administered parenteral drug in the United States. The UDENYCA Autoinjector is a single-use, prefilled device allowing an alternative administering method for pegfilgrastim. The design is user-friendly, permitting reliable, and immediate delivery of the full pegfilgrastim dose upon push-on-skin activation. The autoinjector boasts several advantageous features leading to successful delivery, such as rapid dosing, a straightforward design, dual coverage, flexibility for home or office use, and reduced risk of febrile neutropenia.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927
What regions are dominating the self-administered parenteral market growth?
North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Residential Substance Abuse And Mental Health Facilities Global Market Report 2024
Payer Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/payer-services-global-market-report
Platform as a service (PaaS) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/platform-as-a-service-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
